Graves’ Disease Remission Rate and Associated Factors in Patients with Graves’ disease in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

dc.contributor.advisorTedla Kebede
dc.contributor.authorRahel Teweldebrhan
dc.date.accessioned2026-06-22T15:53:05Z
dc.date.available2026-06-22T15:53:05Z
dc.date.issued2025-04-13
dc.description.abstractBackground: Graves’ disease is an autoimmune disorder. It commonly presents with signs and symptoms of hyperthyroidism. It predominantly affects women in their 3rd to 5th decade. Diagnosis involves clinical evaluation, thyroid function testing and antibody testing. Treatment options include antithyroid drugs, radioactive iodine and thyroidectomy. Limited information is available in sub-Saharan Africa settings. Objectives: This study aims to assess the rate of remission, the time to remission and determine factors associated with and predicting remission of Graves’ disease. Methods: A hospital-based retrospective cross-sectional study design was used. One hundred seventy-six (176) Graves’ hyperthyroidism patients treated and followed up from September 2019 to August 2024 were selected from a teaching referral hospital, Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia. All clinically diagnosed Graves’ disease patients who received only medical treatment for a minimum of 12 months were included in the study. The rate of remission and time to remission in Graves’ disease patients were analyzed using descriptive statistics. Predictors of remission among independent variables were determined first through bivariate logistic regression, followed by multivariate logistic regression to calculate adjusted odds ratios with a 95% confidence interval and a significance threshold of less than 0.05. Results: The study included 176 patients diagnosed with Graves’ hyperthyroidism, with 83.6% achieving euthyroid status and 45.5% attaining remission after antithyroid drug (ATD) therapy. Symptom improvement was reported in 89.2% of patients, while 79.0% showed improved clinical signs. Predictors of remission were explored, and multivariate logistic regression identified the presence of goiter (AOR: 0.282, p = 0.001) and ophthalmopathy (exophthalmos) (AOR: 0.421, p = 0.019) as statistically significant factors negatively impacting remission rates. The findings highlight the efficacy of ATD therapy in achieving euthyroid status and remission, while demonstrating the importance of addressing clinical sig Conclusion: The study identified exophthalmos and goiter as statistically significant predictors leading to non-remission in Graves’ hyperthyroidism. This emphasizes the importance of patient specific management strategies for patients presenting with these clinical features.ns such as goiter and exophthalmos in optimizing patient outcomes.
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/8441
dc.language.isoen_US
dc.publisherAddis Ababa University
dc.subjectDisease Remission Rate
dc.titleGraves’ Disease Remission Rate and Associated Factors in Patients with Graves’ disease in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Rahel_Teweldebrhan_2025_ETD.pdf
Size:
873.29 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: